Continuity of cytokine activation in patients with familial Mediterranean fever
- 1 May 2004
- journal article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 23 (4), 333-337
- https://doi.org/10.1007/s10067-004-0925-4
Abstract
Familial Mediterranean fever (FMF) is a recessively inherited inflammatory disorder, characterized by recurrent attacks of fever and polyserositis. It has been considered that miscellaneous cytokines take part in the pathogenesis of the disease. The aim of this study was to investigate serum levels of soluble interleukin-2 receptor (sIL-2R), interleukin-6 (IL-6), and interleukin-10 (IL-10) in patients with FMF. The study included 42 patients with FMF (3 females, 39 males, mean age: 24.43 years) and 20 healthy volunteers as the control group (18 males, 2 females, mean age: 23.2 years). The patients were chosen according to Eliakim criteria. After recording their history and performing an examination, leukocyte counts, erythrocyte sedimentation rates (ESR), C-reactive protein (CRP), fibrinogen, sIL-2R, IL-6, and IL-10 levels were measured before and during attacks. A significant increase was found in leukocyte (ppppp=0.019) and IL-6 (p<0.001) levels showed significant increases during attacks compared to the levels before an attack. There was no significant difference between IL-10 levels. The levels of the three cytokines were significantly high both before and during the attacks compared to the control group. As a result, the elevation of sIL-2R and IL-6 levels both before and during the attacks compared to control group suggests the existence of continuous cytokine activation in the patients. No significant increase in the IL-10 levels in spite of the significant rise of sIL-2R and IL-6 during attacks supports the notion of inflammation and also reveals that compensation by anti-inflammatory IL-10 does not seem to occur.Keywords
This publication has 23 references indexed in Scilit:
- Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean feverGenes & Immunity, 2002
- Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.Annals Of The Rheumatic Diseases, 1996
- Interleukin-10Annual Review of Immunology, 1993
- Tumor necrosis factor in familial mediterranean feverThe American Journal of Medicine, 1992
- The soluble interleukin‐2 receptor in rheumatic diseaseArthritis & Rheumatism, 1990
- Serum levels of interleukin‐2 receptor and activity of rheumatic diseases characterized by immune system activationArthritis & Rheumatism, 1988
- Guidelines on selection of laboratory tests for monitoring the acute phase response. International Committee for Standardization in Haematology (expert panel on blood rheology).Journal of Clinical Pathology, 1988
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Immunoregulatory abnormalities in familial Mediterranean feverClinical Immunology and Immunopathology, 1981